Skip to main content

Foreign-focused funds dominated the list of the 10 best-performing closed-end funds in July. Health/biotechnology offerings also proved popular with investors.

Two Morgan Stanley funds focusing on the trendy "Chindia" -- China and India -- region rebounded to double-digit gains for the month. However, the

Morgan Stanley China A Share Fund

(CAF) - Get Morgan Stanley China A Share Fund Inc. Report

and the

Morgan Stanley India Investment Fund

(IIF) - Get Morgan Stanley India Investment Fund Inc. Report

each remains in negative territory, down more than 10% for the year to date.

Investors pushed the market price of IIF to a premium of 7.31% at the end of the month from a discount that had averaged 10.57% over the past half year.

Keeping the Chindia pair company and adding geographic diversity to the list were the

Turkish Investment Fund

(TKF)

, which benefited from indications that Turkey's moderately nonsecular government was achieving economic growth in that nation; and

Western Asset Emerging Markets Floating Rate Fund

(EFL) - Get Eaton Vance Floating Rate 2022 Target Term Trust Report

. Whereas domestic floating rate securities have proved a drag on performance of domestic funds, EFL's investments in emerging markets have lifted the fund 33.55% for the year to date.

Scroll to Continue

TheStreet Recommends

Atop the accompany table to July's 10 best performing closed-end funds is the

Engex Fund

(EGX)

, a health/biotechnology offering that vaulted 20.97% for the month, leaving it up 10.78% for the year to date.

Other closed-end funds in the health/biotech area on the list include

H&Q Healthcare Investors

(HQH) - Get Tekla Healthcare Investors Report

and

H&Q Life Sciences Investors

(HQL) - Get Tekla Life Sciences Investors Report

. HQH, which added 8.93% for the monthly, outperformed HQL by a single basis point. Its major portfolio holdings include

Gilead Sciences

(GILD) - Get Gilead Sciences, Inc. Report

,

Teva Pharmaceutical Industries (ADS)

(TEVA) - Get Teva Pharmaceutical Industries Ltd. Report

,

CVS Caremark

(CVS) - Get CVS Health Corporation Report

,

Becton Dickinson

(BDX) - Get Becton, Dickinson and Company Report

and

Baxter International

(BAX) - Get Baxter International Inc. Report

.

A bounce in the financial sector lifted the

John Hancock Bank & Thrift Opportunity Fund

(BTO) - Get John Hancock Financial Opportunities Fund Report

8.55% higher in July. But the fund remains off 14.54% for the year to date and down 22.71% for the latest 12 months. Its largest holdings include financial mainstays

State Street

(STT) - Get State Street Corporation Report

STT,

Bank of New York Mellon

(BK) - Get Bank of New York Mellon Corporation Report

BK,

JP Morgan Chase

(JPM) - Get JPMorgan Chase & Co. Report

,

Wells Fargo

(WFC) - Get Wells Fargo & Company Report

and

Bank of America

(BAC) - Get Bank of America Corp Report

.

Richard Widows is a senior financial analyst for TheStreet.com Ratings. Prior to joining TheStreet.com, Widows was senior product manager for quantitative analytics at Thomson Financial. After receiving an M.B.A. from Santa Clara University in California, his career included development of investment information systems at data firms, including the Lipper division of Reuters. His international experience includes assignments in the U.K. and East Asia.